Correlation Between Crinetics Pharmaceuticals and Fulcrum Therapeutics
Can any of the company-specific risk be diversified away by investing in both Crinetics Pharmaceuticals and Fulcrum Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crinetics Pharmaceuticals and Fulcrum Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crinetics Pharmaceuticals and Fulcrum Therapeutics, you can compare the effects of market volatilities on Crinetics Pharmaceuticals and Fulcrum Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crinetics Pharmaceuticals with a short position of Fulcrum Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crinetics Pharmaceuticals and Fulcrum Therapeutics.
Diversification Opportunities for Crinetics Pharmaceuticals and Fulcrum Therapeutics
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Crinetics and Fulcrum is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Crinetics Pharmaceuticals and Fulcrum Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fulcrum Therapeutics and Crinetics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crinetics Pharmaceuticals are associated (or correlated) with Fulcrum Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fulcrum Therapeutics has no effect on the direction of Crinetics Pharmaceuticals i.e., Crinetics Pharmaceuticals and Fulcrum Therapeutics go up and down completely randomly.
Pair Corralation between Crinetics Pharmaceuticals and Fulcrum Therapeutics
Given the investment horizon of 90 days Crinetics Pharmaceuticals is expected to generate 0.76 times more return on investment than Fulcrum Therapeutics. However, Crinetics Pharmaceuticals is 1.31 times less risky than Fulcrum Therapeutics. It trades about 0.1 of its potential returns per unit of risk. Fulcrum Therapeutics is currently generating about 0.04 per unit of risk. If you would invest 1,605 in Crinetics Pharmaceuticals on September 12, 2024 and sell it today you would earn a total of 4,410 from holding Crinetics Pharmaceuticals or generate 274.77% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Crinetics Pharmaceuticals vs. Fulcrum Therapeutics
Performance |
| Timeline |
| Crinetics Pharmaceuticals |
| Fulcrum Therapeutics |
Crinetics Pharmaceuticals and Fulcrum Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Crinetics Pharmaceuticals and Fulcrum Therapeutics
The main advantage of trading using opposite Crinetics Pharmaceuticals and Fulcrum Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crinetics Pharmaceuticals position performs unexpectedly, Fulcrum Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fulcrum Therapeutics will offset losses from the drop in Fulcrum Therapeutics' long position.| Crinetics Pharmaceuticals vs. Viridian Therapeutics | Crinetics Pharmaceuticals vs. Cytokinetics | Crinetics Pharmaceuticals vs. Structure Therapeutics American | Crinetics Pharmaceuticals vs. Passage Bio |
| Fulcrum Therapeutics vs. RAPT Therapeutics | Fulcrum Therapeutics vs. Mirum Pharmaceuticals | Fulcrum Therapeutics vs. BeyondSpring | Fulcrum Therapeutics vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Stocks Directory Find actively traded stocks across global markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |